WuXi Healthcare Ventures — 2016 Investments

1 investments dated 2016 · listed companies and verified rows first · show all

CStone Pharmaceuticalscstonepharma.com inJul 2016

Hong Kong-listed (HKEX: 2616) Chinese biopharmaceutical company developing oncology, immunology and inflammation therapies.

Co-investorsARCH Venture Partners 6 Dimensions Capital Boyu Capital GIC Hillhouse Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.